ARI0002h

· Fundacion Clinic per a la Recerca Biomédica

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ARI0002h, covering 2023-08-28 to 2025-04-25. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of ARI0002h, for the Initial Treatment of Patients With Primary Plasma Cell Leukaemia [Phase 2]

See pricing